![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Merck Teams Up with Dewpoint for Novel HIV Treatment
Merck Teams Up with Dewpoint for Novel HIV Treatment
Merck has partnered with Boston-based Dewpoint Therapeutics to develop a novel treatment for HIV.
Dewpoint is developing drugs based on biomolecular condensates within cells that it believes play a critical role in a wide range of disease processes, including viral infection.
The Boston company will receive up to $305 million in upfront and milestone payments, as well as royalties on future product sales.
Upcoming Events
-
21Oct